The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo. FDA approves injectable version of ...
Biotest's Fibrinogen Aims to Fulfill a High Unmet Medical Need for Additional Fibrinogen to Treat Acquired Fibrinogen Deficiency US Submission Follows EU Application for Marketing Authorization ...